Market Overview

Sanofi To Buy Genfar

Related SNY
Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes
US Stock Futures Drop; All Eyes On Jobs Report
Regeneron and Sanofi announce pooled data that show Praluent's cholesterol-lowering prowess (Seeking Alpha)

Sanofi SA (NYSE: SNY) announced its plans to buy Colombian group Genfar SA.

Genfar posted sales of $133 million in 2011. The transaction is likely to complete in the first quarter of 2013. However, financial details of the deal were not disclosed.

Sanofi shares closed at $44.02 yesterday.

Posted-In: merger and acquisitionNews M&A


Related Articles (SNY)

Get Benzinga's Newsletters